GILEAD SCIENCES INC Insider Trading for August 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for August 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 19.09 | 10,000 | 190,850 | 15,200 | |
| Aug 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 106.16 | 10,000 | 1,061,618 | 32,244 | 42.2 K to 32.2 K (-23.67 %) |
| Aug 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 19.09 | 10,000 | 190,850 | 42,244 | 32.2 K to 42.2 K (+31.01 %) |
| Aug 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Grant | A | 21.94 | 259 | 5,684 | 32,244 | 32 K to 32.2 K (+0.81 %) |
| Aug 27 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 105.87 | 4,304 | 455,664 | 42,470 | 46.8 K to 42.5 K (-9.20 %) |
| Aug 18 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 40.56 | 33,556 | 1,361,031 | 55,934 | |
| Aug 18 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 95.56 | 33,556 | 3,206,611 | 49,832 | 83.4 K to 49.8 K (-40.24 %) |
| Aug 18 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 40.56 | 33,556 | 1,361,031 | 83,388 | 49.8 K to 83.4 K (+67.34 %) |
| Aug 25 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 14.34 | 5,000 | 71,688 | 71,000 | |
| Aug 25 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 101.09 | 5,000 | 505,440 | 42,405 | 47.4 K to 42.4 K (-10.55 %) |
| Aug 25 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 14.34 | 5,000 | 71,688 | 47,405 | 42.4 K to 47.4 K (+11.79 %) |
| Aug 15 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 4,000 | 0 | 2,154,681 | 2.2 M to 2.2 M (-0.19 %) |
| Aug 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 16,728 | 451,489 | 24,264 | |
| Aug 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 92.04 | 1,303 | 119,930 | 31,985 | 33.3 K to 32 K (-3.91 %) |
| Aug 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 91.54 | 15,425 | 1,411,951 | 33,288 | 48.7 K to 33.3 K (-31.67 %) |
| Aug 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 16,728 | 451,489 | 48,713 | 32 K to 48.7 K (+52.30 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 0.00 | 2,500 | 0 | 17,300 | |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 91.50 | 1,220 | 111,630 | 31,985 | 33.2 K to 32 K (-3.67 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 0.00 | 2,500 | 0 | 33,205 | 30.7 K to 33.2 K (+8.14 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 26.99 | 5,000 | 134,950 | 35,000 | |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 91.00 | 5,000 | 455,000 | 15,641 | 20.6 K to 15.6 K (-24.22 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 26.99 | 5,000 | 134,950 | 20,641 | 15.6 K to 20.6 K (+31.97 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 23.76 | 31,000 | 736,405 | 135,367 | |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 92.07 | 900 | 82,864 | 124,694 | 125.6 K to 124.7 K (-0.72 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 91.15 | 1,100 | 100,266 | 125,594 | 126.7 K to 125.6 K (-0.87 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 92.10 | 13,134 | 1,209,634 | 126,694 | 139.8 K to 126.7 K (-9.39 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 91.27 | 17,866 | 1,630,567 | 139,828 | 157.7 K to 139.8 K (-11.33 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 23.76 | 31,000 | 736,405 | 157,694 | 126.7 K to 157.7 K (+24.47 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 24.91 | 3,000 | 74,715 | 0 | |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 24.30 | 11,250 | 273,319 | 67,500 | |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 23.76 | 4,800 | 114,024 | 9,600 | |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 19.09 | 11,550 | 220,432 | 23,100 | |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 92.09 | 8,100 | 745,913 | 49,832 | 57.9 K to 49.8 K (-13.98 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 91.26 | 22,500 | 2,053,436 | 57,932 | 80.4 K to 57.9 K (-27.97 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 24.91 | 3,000 | 74,715 | 80,432 | 77.4 K to 80.4 K (+3.87 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 24.30 | 11,250 | 273,319 | 77,432 | 66.2 K to 77.4 K (+17.00 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 23.76 | 4,800 | 114,024 | 66,182 | 61.4 K to 66.2 K (+7.82 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 19.09 | 11,550 | 220,432 | 61,382 | 49.8 K to 61.4 K (+23.18 %) |
| Aug 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 562,508 | |
| Aug 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 92.10 | 41,500 | 3,822,017 | 4,429,387 | 4.5 M to 4.4 M (-0.93 %) |
| Aug 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 91.30 | 99,125 | 9,049,795 | 4,470,887 | 4.6 M to 4.5 M (-2.17 %) |
| Aug 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |